-
公开(公告)号:US20160318917A1
公开(公告)日:2016-11-03
申请号:US15105306
申请日:2014-12-17
发明人: Jeffrey Charles Boehm , Thomas Glanmor Davies , Alison Jo-anne Woolford , Charlotte Mary Griffiths-Jones , Hendrika Maria Gerarda Willems , David Norton , Gordon Saxity , Thomas Daniel Heightman , Tindy Li , Jeffrey K. Kerns , Roderick S. Davis , Hongxing Yan
IPC分类号: C07D417/10 , C07D515/04 , C07D401/12 , C07D513/04 , C07D249/18 , C07D291/08 , C07D471/04 , C07D417/14 , C07D403/12 , C07D419/14 , C07D281/02 , C07D419/10 , C07D405/12
CPC分类号: C07D417/10 , C07D249/18 , C07D281/02 , C07D291/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D417/14 , C07D419/10 , C07D419/14 , C07D471/04 , C07D513/04 , C07D515/04
摘要: The present invention relates to bis aryl analogs, pharmaceutical compositions containing them and their use as Nrf2 regulators.
摘要翻译: 本发明涉及双芳基类似物,含有它们的药物组合物及其作为Nrf2调节剂的用途。
-
公开(公告)号:US20190224212A1
公开(公告)日:2019-07-25
申请号:US16375047
申请日:2019-04-04
发明人: Jeffrey K. Kerns , James Francis Callahan , Hongxing Yan , Thomas Daniel Heightman , Jeffrey Charles Boehm , Alison Jo-Anne Woolford
IPC分类号: A61K31/5513 , A61K31/421 , A61K31/403 , A61P11/00 , C07D519/00 , C07D403/06 , C07D267/14 , C07D413/10 , C07D413/06 , C07D498/04
摘要: The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
-
公开(公告)号:US20230047296A1
公开(公告)日:2023-02-16
申请号:US17495115
申请日:2021-10-06
发明人: Jeffrey K. KERNS , James Callahan , Hongxing Yan , Thomas Daniel Heightman , Charlotte Mary Griffiths-Jones , Alison Jo-Anne Woolford , Tindy Li , Ami Lakdawala Shah , Roderick S. Davis , David Norton , Jeffrey Charles Boehm , Paris L. Hamilton , Nicole Cathleen Goodwin , Yun Jin
IPC分类号: C07D403/10 , C07D401/14 , C07D405/14 , C07D413/14 , C07D401/10 , C07D403/14 , C07D413/10 , C07D471/04 , C07D487/04 , C07D498/04 , C07D267/14 , C07D249/18 , C07D233/60 , C07D487/08 , C07D451/02 , A61P9/00 , A61P25/00 , A61P11/00 , A61P27/00 , A61P35/00 , A61P37/00 , C07D233/64 , C07D255/04 , C07D273/01 , C07D405/10
摘要: The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
-
公开(公告)号:US10604509B2
公开(公告)日:2020-03-31
申请号:US15736075
申请日:2016-06-15
发明人: Jeffrey K. Kerns , James Callahan , Thomas Daniel Heightman , Alison Jo-Anne Woolford , Ami Lakdawala Shah , Roderick S. Davis , David Norton , Jeffrey Charles Boehm , Nicole Cathleen Goodwin
IPC分类号: C07D417/10 , C07D403/10 , C07D249/04 , C07D249/18 , C07D401/14 , C07D405/14 , C07D413/14 , C07D401/10 , C07D403/14 , C07D413/10 , C07D471/04 , C07D487/04 , C07D498/04 , C07D267/14 , C07D233/60 , C07D487/08 , C07D451/02 , A61P9/00 , A61P25/00 , A61P11/00 , A61P27/00 , A61P35/00 , A61P37/00 , C07D233/64 , C07D255/04 , C07D273/01 , C07D405/10
摘要: Provided are aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
-
公开(公告)号:US10272095B2
公开(公告)日:2019-04-30
申请号:US15735977
申请日:2016-06-15
发明人: Jeffrey K. Kerns , James Francis Callahan , Hongxing Yan , Thomas Daniel Heightman , Jeffrey Charles Boehm , Alison Jo-Anne Woolford
IPC分类号: A61K31/5513 , A61K31/421 , A61K31/403 , A61P11/00 , C07D403/06 , C07D413/06 , C07D413/10 , C07D267/14 , C07D498/04 , C07D519/00
摘要: The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
-
公开(公告)号:US20200079759A1
公开(公告)日:2020-03-12
申请号:US16675634
申请日:2019-11-06
发明人: Jeffrey K. KERNS , James Callahan , Hongxing Yan , Thomas Daniel Heightman , Charlotte Mary Griffiths-Jones , Alison Jo-Anne Woolford , Tindy Li , Ami Lakdawala Shah , Roderick S. Davis , David Norton , Jeffrey Charles Boehm , Paris L. Hamilton , Nicole Cathleen Goodwin , Yun Jin
IPC分类号: C07D403/10 , C07D267/14 , C07D249/18 , C07D233/60 , C07D487/08 , C07D451/02 , A61P9/00 , A61P25/00 , A61P11/00 , A61P27/00 , A61P35/00 , A61P37/00 , C07D401/14 , C07D405/14 , C07D413/14 , C07D401/10 , C07D403/14 , C07D413/10 , C07D471/04 , C07D487/04 , C07D498/04 , C07D233/64 , C07D255/04 , C07D273/01 , C07D405/10
摘要: The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.
-
-
-
-
-